Klotho and PPAR Gamma Activation Mediate the Renoprotective Effect of Losartan in the 5/6 Nephrectomy Model
Renin angiotensin system (RAS) blockade reduces the progression of chronic kidney disease (CKD) independently of its antihypertensive effect. Ang II-induced fibrosis can be mediated by molecules such as klotho, peroxisome proliferator-activate receptor γ (PPAR-γ), and the Wnt/β-catenin pathway; howe...
Main Authors: | Edgar Maquigussa, Josne C. Paterno, Gabriel H. de Oliveira Pokorny, Mariana da Silva Perez, Vanessa A. Varela, Antônio da Silva Novaes, Nestor Schor, Mirian A. Boim |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-08-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphys.2018.01033/full |
Similar Items
-
Klotho and the Treatment of Human Malignancies
by: Aishani Sachdeva, et al.
Published: (2020-06-01) -
The role of klotho in systemic sclerosis
by: R. Talotta, et al.
Published: (2017-12-01) -
Klotho as a Novel Cardioprotective Protein in Aged Heart
by: Ali Dehghani, et al.
Published: (2018-12-01) -
Klotho, Aging, and the Failing Kidney
by: Sarah Buchanan, et al.
Published: (2020-08-01) -
Klotho, stem cells, and aging
by: Bian A, et al.
Published: (2015-08-01)